These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 17053291
1. The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves' disease. Tsuboi K, Ueshiba H, Shimojo M, Ishikawa M, Watanabe N, Nagasawa K, Yuasa R, Yoshino G. Endocr J; 2007 Feb; 54(1):39-43. PubMed ID: 17053291 [Abstract] [Full Text] [Related]
2. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Takata K, Kubota S, Fukata S, Kudo T, Nishihara E, Ito M, Amino N, Miyauchi A. Thyroid; 2009 Jun; 19(6):559-63. PubMed ID: 19445623 [Abstract] [Full Text] [Related]
3. Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil. Yoshimura Noh J, Inoue K, Suzuki N, Yoshihara A, Fukushita M, Matsumoto M, Imai H, Hiruma S, Ichikawa M, Koshibu M, Sankoda A, Hirose R, Watanabe N, Sugino K, Ito K. Endocr J; 2024 Jul 12; 71(7):695-703. PubMed ID: 38710619 [Abstract] [Full Text] [Related]
5. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis. Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE. J Clin Endocrinol Metab; 1984 May 12; 58(5):868-72. PubMed ID: 6200492 [Abstract] [Full Text] [Related]
13. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N. J Clin Endocrinol Metab; 2007 Jun 12; 92(6):2157-62. PubMed ID: 17389704 [Abstract] [Full Text] [Related]
14. A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment. Reinwein D, Benker G, Lazarus JH, Alexander WD. J Clin Endocrinol Metab; 1993 Jun 12; 76(6):1516-21. PubMed ID: 8501160 [Abstract] [Full Text] [Related]
15. Adverse effects related to thionamide drugs and their dose regimen. Werner MC, Romaldini JH, Bromberg N, Werner RS, Farah CS. Am J Med Sci; 1989 Apr 12; 297(4):216-9. PubMed ID: 2523194 [Abstract] [Full Text] [Related]
16. Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis. Dai WX, Zhang JD, Zhan SW, Xu BZ, Jin H, Yao Y, Xin WC, Bai Y. Endocr J; 2002 Feb 12; 49(1):29-33. PubMed ID: 12008747 [Abstract] [Full Text] [Related]
18. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease. Takata K, Amino N, Kubota S, Sasaki I, Nishihara E, Kudo T, Ito M, Fukata S, Miyauchi A. Clin Endocrinol (Oxf); 2010 Jun 12; 72(6):845-50. PubMed ID: 19912243 [Abstract] [Full Text] [Related]
19. [Change in serum G-CSF levels in patients with Graves' disease by treatment with methimazole]. Hara H, Ban Y, Sato R, Ishikawa N, Yoshimura H, Hisaoka T, Ito K. Nihon Naibunpi Gakkai Zasshi; 1992 Oct 20; 68(10):1121-9. PubMed ID: 1281122 [Abstract] [Full Text] [Related]